Drug comparisons
Linagliptin vs Pioglitazone
Compare Linagliptin (Tradjenta) vs Pioglitazone (Actos) for type 2 diabetes. Differences in DPP-4 vs TZD action, side effects, heart failure risk, and suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when choosing between a DPP-4 inhibitor and a thiazolidinedione for type 2 diabetes patients with insulin resistance or cardiovascular concerns.
Bottom line
The preferred agent depends on patient-specific risks such as heart failure, weight, and renal function rather than one being inherently superior.
All medication comparisons